| RS797044439 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS797044440 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS797044441 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Autosomal dominant hypocalcemia 1 |
| RS797044442 |
PHKB
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXb, Glycogen phosphorylase kinase deficiency |
| RS797044444 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS797044445 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS797044446 |
PLOD1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS797044447 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS797044448 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS797044449 |
GH1
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency type IB, Isolated growth hormone deficiency type IB |
| RS797044450 |
GH1
|
Health Risk |
Pathogenic |
Autosomal dominant isolated somatotropin deficiency, Autosomal dominant isolated somatotropin deficiency |
| RS797044451 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation syndrome |
| RS797044452 |
GNRHR
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 7 with or without anosmia, Hypogonadotropic hypogonadism 7 with or without anosmia |
| RS797044453 |
F13B
|
Health Risk |
Pathogenic |
Factor XIII, b subunit |
| RS797044454 |
TYMP
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial neurogastrointestinal encephalomyopathy |
| RS797044455 |
TYMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS797044456 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS797044457 |
COL6A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS797044458 |
COL6A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 1A, Ullrich congenital muscular dystrophy 1A |
| RS797044459 |
COL1A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, cardiac valvular type |
| RS797044460 |
AKR1C2
|
Health Risk |
Pathogenic |
46, XY disorder of sex development due to testicular 17 |
| RS797044461 |
ORC4
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 2, Meier-Gorlin syndrome 2 |
| RS797044462 |
FAM20C
|
Health Risk |
Pathogenic |
Lethal osteosclerotic bone dysplasia, Lethal osteosclerotic bone dysplasia |
| RS797044463 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS797044464 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS797044465 |
KIF7
|
Health Risk |
Pathogenic |
Joubert syndrome 12, Joubert syndrome 12 |
| RS797044466 |
KIF7
|
Health Risk |
Pathogenic |
JOUBERT SYNDROME 12/15, DIGENIC |
| RS797044467 |
DPM2
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy with intellectual disability and severe epilepsy, Congenital muscular dystrophy with intellectual disability and severe epilepsy |
| RS797044468 |
INPPL1
|
Health Risk |
Pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS797044469 |
INPPL1
|
Health Risk |
Pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS797044470 |
INPPL1
|
Health Risk |
Pathogenic |
Opsismodysplasia, Opsismodysplasia |
| RS797044471 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS797044477 |
WAS
|
Health Risk |
Pathogenic |
X-linked severe congenital neutropenia, Thrombocytopenia 1 |
| RS797044479 |
SERPINB7
|
Health Risk |
Pathogenic |
Palmoplantar keratoderma, Nagashima type |
| RS797044481 |
CDKN1B
|
Health Risk |
Likely pathogenic |
Neuroendocrine neoplasm, Neuroendocrine neoplasm |
| RS797044482 |
CDKN1B
|
Health Risk |
Pathogenic |
Neuroendocrine neoplasm, Hereditary cancer-predisposing syndrome |
| RS797044483 |
CDKN1B
|
Health Risk |
Likely pathogenic |
Neuroendocrine neoplasm, Neuroendocrine neoplasm |
| RS797044484 |
TP63
|
Health Risk |
Pathogenic |
Ectrodactyly, ectodermal dysplasia |
| RS797044487 |
LMNA
|
Health Risk |
Pathogenic |
Hutchinson-Gilford progeria syndrome, atypical |
| RS797044488 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hutchinson-Gilford syndrome, Hutchinson-Gilford progeria syndrome |
| RS797044489 |
MYO7A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS797044490 |
MYO7A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS797044491 |
MYO7A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Hearing loss |
| RS797044492 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome type 1 |
| RS797044495 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS797044496 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS797044497 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS797044498 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS797044499 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS797044500 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS797044502 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS797044503 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS797044504 |
MTM1
|
Health Risk |
Pathogenic |
— |
| RS797044505 |
PGK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to phosphoglycerate kinase 1 deficiency, Glycogen storage disease due to phosphoglycerate kinase 1 deficiency |
| RS797044507 |
RP2
|
Health Risk |
Pathogenic |
— |
| RS797044508 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Thyroid cancer |
| RS797044509 |
SALL4
|
Health Risk |
Pathogenic |
— |
| RS797044510 |
MYO7A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 2 |
| RS797044511 |
MYO7A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 2 |
| RS797044512 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Autosomal dominant nonsyndromic hearing loss 11 |
| RS797044513 |
MYO7A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Retinal dystrophy |
| RS797044514 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome, Usher syndrome |
| RS797044516 |
MYO7A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Autosomal recessive nonsyndromic hearing loss 2 |
| RS797044518 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Usher syndrome type 1 |
| RS797044519 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS797044520 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related disorder |
| RS797044521 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, Complex neurodevelopmental disorder |
| RS797044522 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS797044523 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, Inborn genetic diseases |
| RS797044524 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS797044525 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS797044526 |
DYRK1A
|
Health Risk |
Pathogenic/Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS797044527 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS797044528 |
FOXL2
|
Health Risk |
Pathogenic |
BLEPHAROPHIMOSIS, PTOSIS |
| RS797044529 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS797044531 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS797044532 |
FOXL2
|
Health Risk |
Pathogenic |
BLEPHAROPHIMOSIS, PTOSIS |
| RS797044534 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS797044540 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS797044542 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS797044544 |
KCNT1
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Autosomal dominant nocturnal frontal lobe epilepsy 5 |
| RS797044545 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS797044546 |
DEPDC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, familial focal |
| RS797044547 |
TBC1D24
|
Health Risk |
Pathogenic |
DOORS syndrome, DOORS syndrome |
| RS797044548 |
TBC1D24
|
Health Risk |
Pathogenic |
DOORS syndrome, DOORS syndrome |
| RS797044549 |
TBC1D24
|
Health Risk |
Pathogenic |
DOORS syndrome, DOORS syndrome |
| RS797044552 |
DCC
|
Health Risk |
Pathogenic |
Mirror movements 1, Mirror movements 1 |
| RS797044553 |
DCC
|
Health Risk |
Pathogenic |
Mirror movements 1, Mirror movements 1 |
| RS797044556 |
DCC
|
Health Risk |
Pathogenic |
Mirror movements 1, Mirror movements 1 |
| RS797044558 |
ABCB7
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia, X-linked |
| RS797044559 |
FKBP10
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS797044561 |
RP2
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, X-linked retinitis pigmentosa |
| RS797044563 |
ATRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS797044565 |
KMT2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS797044566 |
ATN1
|
Health Risk |
Likely pathogenic |
Congenital hypotonia, epilepsy |
| RS797044567 |
G6PC3
|
Health Risk |
Pathogenic |
Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency, Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency |
| RS797044568 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS797044569 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS797044570 |
GFAP
|
Health Risk |
Likely pathogenic |
Alexander disease, Alexander disease |
| RS797044571 |
GFAP
|
Health Risk |
Pathogenic |
— |